Bryan M. Webb - Concepedia

Author

Bryan M. Webb

Case Western Reserve University ORCID

Also Known As

Bryan M Webb, Bryan M. Webb, Bryan Webb

128

Publications

440

Citations

H-Index

Concepts

All Affiliations

Case Western Reserve University The Ohio State University

About

Bryan M. Webb is an author at Case Western Reserve University specializing in tumor biology, cell biology, and cancer biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	178
2	Cell Biology	2	2	178
3	Engineering	1	1	68
4	Health Sciences	1	1	68
5	Biomedical Engineering	1	1	68

Bryan M. Webb

Publications

427

Citations

H-Index

Page 1

	Year	Citations
CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells Amar Desai, Bryan M. Webb, Stanton L. Gerson Radiotherapy and Oncology Cell RegulationDna Repair GenesAltered RegulationMedicineOncogenic Agent	2014	122
Quantification of cardiac fiber orientation using optical coherence tomography Christine P. Fleming, Crystal M. Ripplinger, Bryan M. Webb, Journal of Biomedical Optics Heart FailureEngineeringBiomedical EngineeringTissue ImagingFiber Orientation	2008	68
Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells Sylvia S. Gayle, Jennifer M. Sahni, Bryan M. Webb, Journal of Biological Chemistry	2018	59
Bromodomain and Extraterminal Protein Inhibition Blocks Growth of Triple-negative Breast Cancers through the Suppression of Aurora Kinases Jennifer M. Sahni, Sylvia S. Gayle, Kristen L. Weber-Bonk, Journal of Biological Chemistry Breast OncologyTriple-negative Breast CancersMedicineBreast CancerAurora Kinases	2016	56
The transcriptional repressor BCL11A promotes breast cancer metastasis Darcie D. Seachrist, Molly M. Hannigan, Natasha N. Ingles, Journal of Biological Chemistry	2020	47
Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors Jennifer M. Sahni, Sylvia S. Gayle, Bryan M. Webb, Cancer Research	2017	31
KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene Melyssa S. Roberts, Lindsey J. Anstine, Viviane S. Finke, Breast Cancer Research	2020	31
TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters Bryan M. Webb, Benjamin L. Bryson, Eduardo Williams-Medina, Journal of Biological Chemistry	2021	13

Page 1